We've found
342
archived clinical trials in
Postherpatic Neuralgia
We've found
342
archived clinical trials in
Postherpatic Neuralgia
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Updated: 9/12/2013
A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Status: Enrolling
Updated: 9/12/2013
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Updated: 9/12/2013
A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Status: Enrolling
Updated: 9/12/2013
Click here to add this to my saved trials
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Updated: 9/12/2013
A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Status: Enrolling
Updated: 9/12/2013
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Updated: 9/12/2013
A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Status: Enrolling
Updated: 9/12/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Updated: 12/31/2013
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia
Updated: 7/8/2015
A Phase 2A, Randomized, Blinded, Placebo- and Active-controlled, 2-Period Crossover Study to Assess the Analgesic Efficacy, Safety, and Tolerability of ADL5747 in Subjects With Postherpetic Neuralgia
Status: Enrolling
Updated: 7/8/2015
Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia
Updated: 7/8/2015
A Phase 2A, Randomized, Blinded, Placebo- and Active-controlled, 2-Period Crossover Study to Assess the Analgesic Efficacy, Safety, and Tolerability of ADL5747 in Subjects With Postherpetic Neuralgia
Status: Enrolling
Updated: 7/8/2015
Click here to add this to my saved trials
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
Status: Enrolling
Updated: 10/20/2015
Updated: 10/20/2015
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
Status: Enrolling
Updated: 10/20/2015
Updated: 10/20/2015
Click here to add this to my saved trials
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
Status: Enrolling
Updated: 10/20/2015
Updated: 10/20/2015
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
Status: Enrolling
Updated: 10/20/2015
Updated: 10/20/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Crossover Post-herpetic Neuralgia (PHN)
Updated: 11/6/2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Click here to add this to my saved trials